Avadel was acquired by Alkermes plc. on February 11, 2026, according to the Form 8-K Alkermes plc. filed with the SEC. The filing states a price of $1.5 billion. It is the only completed acquisition Alkermes plc. reported under Item 2.01 in the last twelve months (Form 8-K, February 12, 2026).
1 companies announced an acquisition this week.
Companies in an acquisition this week, and the deal. Before you unlock: the company, the deal and what is inside. After: every way we found to reach the company, and anyone a source names. A team joining the buyer is labelled only when the filing itself says so.
| Bowman Consulting Group Ltd. | agreed to be acquired by Prive Parent, Inc. |
Competing with, selling to or investing in Alkermes plc. after this deal? See the free Snapshot first.
Free to see. No signup.
Alkermes plc. completed its acquisition of Avadel on 2026-02-11, according to the Form 8-K Alkermes plc. filed with the SEC on 2026-02-12. The filing states a price of $1.5 billion.
| Acquirer | Alkermes plc. |
|---|---|
| Acquired | Avadel |
| Completed | 2026-02-11 |
| Price stated in the filing | $1.5 billion |
| Reported by | Alkermes plc. (ALKS), the buyer |
| Filing | Form 8-K, filed 2026-02-12 |
Want the whole picture on Alkermes plc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Alkermes plc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alkermes plc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What the filing says
At the Effective Time, the Company acquired all of the issued and outstanding ordinary shares of Avadel, nominal value $0.01 per share (the "Avadel Shares"), other than Avadel Shares held by Alkermes or any of its concert parties (if any), and each holder of Avadel Shares outstanding as of 11:59 p.m., New York City time, on February 11, 2026, the business day prior to the occurrence of the Effective Time, became entitled to receive (i) $21.00 in cash (the "Cash Consideration") for each Avadel Share and (ii) one non-transferable contingent value right (a "CVR") for each Avadel Share, in each case in accordance with the terms of the Scheme and the Contingent Value Rights Agreement entered into at or prior to the Effective Time (the "CVR Agreement"), substantially in the form attached as Exhibit A to the Original Transaction Agreement.
How much did Alkermes plc. pay for Avadel?
below) and the Company's entry into the Credit Agreement (as described in Item 1.01 above), the Company terminated the previously disclosed amended and restated bridge term loan credit agreement by and among the Company, as the TopCo Borrower, Alkermes, Inc., as the U.S. Borrower, JPMorgan Chase Bank, N.A., as Administrative Agent, Sole Lead Arranger and Sole Bookrunner, and the lenders party thereto (the "Bridge Credit Agreement") entered into on November 18, 2025, which provided for a senior secured bridge term loan facility in an aggregate amount of up to approximately $1.5 billion to fund the Acquisition.
More from the filing
The Bridge Credit Agreement was terminated as the commitments under the Credit Agreement, together with the Company's cash on hand, were sufficient to fund the Acquisition.
Item 2.01 Completion of Acquisition or Disposition of Assets.
On February 12, 2026, the Company and Avadel Pharmaceuticals plc ("Avadel"), completed the transactions contemplated by the previously announced Transaction Agreement (the "Original Transaction Agreement") dated October 22, 2025, as amended by Amendment No.1 to the Transaction Agreement (the "Amendment") dated November 18, 2025, by and between the Company and Avadel (as amended, the "Transaction Agreement").
Quoted from Alkermes plc.'s Form 8-K.
This is the only completed acquisition Alkermes plc. reported under Item 2.01 in the last twelve months.
Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Alkermes plc.Look up Alkermes plc. first. Finding the company and seeing how much is on record uses no credits.
Look up Alkermes plc.Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.
Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.